Document is current
Any future updates will be listed below
-
Authors
Yeow, Yen Ling
Kotamraju, Venkata Ramana
Wang, Xiao
Chopra, Meenu
Azme, Nasibah
Wu, Jiansha
Schoep, Tobias D
Delaney, Derek S https://orcid.org/0000-0002-1185-121X
Feindel, Kirk
Li, Ji
Kennedy, Kelsey M
Allen, Wes M
Kennedy, Brendan F
Larma, Irma
Sampson, David D
Mahakian, Lisa M
Fite, Brett Z
Zhang, Hua
Friman, Tomas
Mann, Aman P
Aziz, Farah A
Kumarasinghe, M Priyanthi
Johansson, Mikael
Ee, Hooi C
Yeoh, George
Mou, Lingjun
Ferrara, Katherine W
Billiran, Hector
Ganss, Ruth
Ruoslahti, Erkki
Hamzah, Juliana https://orcid.org/0000-0002-3802-5073
-
Funding
Funding for this research was provided by:
Department of Health|National Health and Medical Research Council (APP1058073)
Department of Health|National Health and Medical Research Council (APP1121131)
Department of Health|National Health and Medical Research Council (APP1046507)
Center for Strategic Scientific Initiatives, National Cancer Institute (CA188883)
HHS|NIH|National Cancer Institute (NIHCA210553)
Cancer Council Western Australia
University, State and Commonwealth Governments
- License Information
-
More Information
Article History
Received: 27 May 2019
Revised: 26 September 2019
Accepted: 9 October 2019
First Online: 11 November 2019
Conflict of interest
: OncoRes Medical Pty Ltd is developing optical elastography for applications in breast‐conserving surgery. B.F.K., K.M.K and D.D.S. have shares in OncoRes Medical, and B.F.K. is undertaking funded research for this company. J.H., R.G. and E.R. filed a patent on the biomedical applications of CSG and TNFα‐CSG. (patent title: “Novel biomolecule conjugate and uses therefor”, international application number: PCT/AU2017/050037; applicants: University of Western Australia and Sanford Burnham Prebys Medical Discovery Institute.)
